Randomized trial in EUS-FNB for solid pancreatic lesions
- Conditions
- Solid pancreatic lesions not less than 10 mmPancreas
- Registration Number
- JPRN-jRCT1042220099
- Lead Sponsor
- Ishikawa Takuya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 192
(1)Patients with solid pancreatic lesions not less than 10 mm on CT or MRI which require histological diagnosis by EUS-FNB.
(2)Patients over 20 years old at the time of enrollment.
(3)Preservation of bone marrow function at the time of diagnosis.
(4)Patients in which antithrombotic drugs are not used within one week or can be withdrawn or replaced.
(5)Provision of written consent to participate in the study.
(1)Uncontrollable infection including active tuberculosis
(2)Serious adverse events
(3)Severe mental disorder
(4)Judgement as being ineligible by the principal or subinvestigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Histological tissue collection rate
- Secondary Outcome Measures
Name Time Method Histological tissue collection rate among new needles<br>Histological diagnostic ability<br>Puncture success rate at first shot<br>Evaluation of the easiness of the puncture<br>Adverse events<br>Comparison of core tissue length and area